80 related articles for article (PubMed ID: 21766672)
1. [Basic approach to choose anti-diabetic drugs].
Hirukawa H; Kaku K
Nihon Rinsho; 2011 Jan; 69 Suppl 1():626-31. PubMed ID: 21766672
[No Abstract] [Full Text] [Related]
2. Early pharmacological intervention in newly diagnosed metabolic syndrome and type 2 diabetes.
Naruszewicz M
Przegl Lek; 2006; 63 Suppl 4():7-8. PubMed ID: 16967707
[No Abstract] [Full Text] [Related]
3. [Alpha-Glucosidase inhibitors].
Horikawa Y; Takeda J
Nihon Rinsho; 2011 Jan; 69 Suppl 1():641-4. PubMed ID: 21766675
[No Abstract] [Full Text] [Related]
4. [Sulfonylureas and glinides].
Kudo K; Hirose T
Nihon Rinsho; 2011 Jan; 69 Suppl 1():645-53. PubMed ID: 21766676
[No Abstract] [Full Text] [Related]
5. [Sulfonylureas and glinides].
Hirose T
Nihon Rinsho; 2006 Dec; 64 Suppl 9():646-53. PubMed ID: 17458297
[No Abstract] [Full Text] [Related]
6. Acute heart failure in a patient with metabolic syndrome and diabetes mellitus: clinical evidence for direct positive influence of antidiabetic therapy on left ventricular function.
Ritzel A; Bell M; Jensen C; Sabin G
Congest Heart Fail; 2009; 15(3):148-50. PubMed ID: 19522965
[No Abstract] [Full Text] [Related]
7. [Evidences demonstrating the effects of prevention of major adverse cardiovascular events and anti-atherosclerotic actions of pioglitazone--special emphasis on PROactive study and PERISCOPE study].
Kawamori R
Nihon Rinsho; 2011 Jan; 69 Suppl 1():671-7. PubMed ID: 21766679
[No Abstract] [Full Text] [Related]
8. [Alpha glucosidase inhibitor].
Katsuta H; Ishida H
Nihon Rinsho; 2006 Dec; 64 Suppl 9():637-45. PubMed ID: 17458296
[No Abstract] [Full Text] [Related]
9. AMPK: an emerging drug target for diabetes and the metabolic syndrome.
Zhang BB; Zhou G; Li C
Cell Metab; 2009 May; 9(5):407-16. PubMed ID: 19416711
[TBL] [Abstract][Full Text] [Related]
10. Effective treatments for insulin resistance: trim the fat and douse the fire.
Evans JL; Youngren JF; Goldfine ID
Trends Endocrinol Metab; 2004 Nov; 15(9):425-31. PubMed ID: 15519889
[TBL] [Abstract][Full Text] [Related]
11. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and treatment of metabolic syndrome in adolescents with type 2 diabetes.
Sanders BH; Lubsch LM; West DS
Ann Pharmacother; 2006 Sep; 40(9):1517-21. PubMed ID: 16896016
[TBL] [Abstract][Full Text] [Related]
13. Nutraceuticals in diabetes and metabolic syndrome.
Davì G; Santilli F; Patrono C
Cardiovasc Ther; 2010 Aug; 28(4):216-26. PubMed ID: 20633024
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics of the therapy of patients with type II diabetes mellitus and metabolic syndrome].
Bodnar PM; Kononenko LO
Lik Sprava; 2000; (7-8):92-4. PubMed ID: 16786661
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Piccinni MN; Fogari E; Salvadeo S; Ciccarelli L; Fogari R
Diabetes Res Clin Pract; 2005 Jul; 69(1):5-13. PubMed ID: 15955382
[TBL] [Abstract][Full Text] [Related]
16. [Diabetes 2: it is possible to prevent it].
Rubin P
Servir; 2004; 52(5):251-4. PubMed ID: 15600064
[No Abstract] [Full Text] [Related]
17. Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity.
Hoppin AG; Katz ES; Kaplan LM; Lauwers GY
N Engl J Med; 2006 Oct; 355(15):1593-602. PubMed ID: 17035653
[No Abstract] [Full Text] [Related]
18. Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome.
Isaacsohn JL; Troendle AJ; Orloff DG
Am J Cardiol; 2004 Jun; 93(11A):49C-52C. PubMed ID: 15178516
[No Abstract] [Full Text] [Related]
19. Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?
Joffe D; Yanagisawa RT
Med Clin North Am; 2007 Nov; 91(6):1107-23, ix. PubMed ID: 17964912
[TBL] [Abstract][Full Text] [Related]
20. Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance.
de Aguiar LG; Bahia LR; Villela N; Laflor C; Sicuro F; Wiernsperger N; Bottino D; Bouskela E
Diabetes Care; 2006 May; 29(5):1083-9. PubMed ID: 16644641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
